PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 234, Issue 4, Pages 502-513
Publisher
Wiley
Online
2014-07-30
DOI
10.1002/path.4412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit
- (2014) H. Koeppen et al. CLINICAL CANCER RESEARCH
- p21-Activated protein kinases and their emerging roles in glucose homeostasis
- (2013) Yu-ting Alex Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pak1 Kinase Links ErbB2 to -Catenin in Transformation of Breast Epithelial Cells
- (2013) L. E. Arias-Romero et al. CANCER RESEARCH
- Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2013) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma
- (2013) Christy C. Ong et al. JNCI-Journal of the National Cancer Institute
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
- (2013) M. Merchant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model
- (2012) H. Y. Chow et al. CANCER RESEARCH
- Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations
- (2012) J. Eswaran et al. CLINICAL CANCER RESEARCH
- Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events
- (2012) J. Liu et al. GENOME RESEARCH
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes
- (2012) Jeffrey J. Wallin et al. PLoS One
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
- (2011) K. P. Hoeflich et al. CANCER RESEARCH
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- Inhibition or Ablation of p21-activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanismsin Vivo
- (2011) Zhanxiang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
- (2011) Y Shrestha et al. ONCOGENE
- Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer
- (2011) Lei Zheng et al. PLoS One
- Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
- (2011) C. C. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
- (2011) D. V. T. Catenacci et al. Cancer Discovery
- Signalling to cancer cell invasion through PAK family kinases
- (2010) Andrew Whale Frontiers in Bioscience-Landmark
- PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion
- (2010) C. M. Wells et al. JOURNAL OF CELL SCIENCE
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- PAK1 and PAK2 have different roles in HGF-induced morphological responses
- (2009) Michael D. Bright et al. CELLULAR SIGNALLING
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
- (2009) Christine A. Iacobuzio-Donahue et al. JOURNAL OF CLINICAL ONCOLOGY
- PAK1 interacts with β-catenin and is required for the regulation of the β-catenin signalling pathway by gastrins
- (2008) Hong He et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- (2008) H. Jin et al. CANCER RESEARCH
- An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase
- (2008) Sean W. Deacon et al. CHEMISTRY & BIOLOGY
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started